Log in to save to my catalogue

SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironme...

SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironme...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3a8a14f3b4be4c53a830c86d90213945

SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma

About this item

Full title

SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2022-12, Vol.13 (12), p.1071-1071, Article 1071

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Glioma is the most common type of primary malignant tumor in the central nervous system with limited treatment satisfaction. Finding new therapeutic targets has remained a major challenge. Ferroptosis is a novel and distinct type of programmed cell death, playing a regulatory role in the progression of tumors. However, the role of ferroptosis or fe...

Alternative Titles

Full title

SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3a8a14f3b4be4c53a830c86d90213945

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3a8a14f3b4be4c53a830c86d90213945

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-022-05526-w

How to access this item